Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Capital Reinvestment Ratio
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A capital reinvestment ratio. Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (301290) has a Capital Reinvestment Ratio of 0.92x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥126.49 Million) in capital expenditures (CN¥115.96 Million). Check total reinvestment intensity of Jiangsu Canopus Wisdom Medical Technolog to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A (2020–2024)
Capital reinvestment ratio of Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A from 2020 to 2024. This chart tracks Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A's Capital Reinvestment Ratio across 5 annual periods. Also explore 301290 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A Capital Reinvestment Ratio by Year (2020–2024)
Jiangsu Canopus Wisdom Medical Technology Co. Ltd. A capital reinvestment ratio by year from 2020 to 2024. For the full cash flow conversion analysis, see Jiangsu Canopus Wisdom Medical Technolog (301290) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.92x | CN¥126.49 Million | CN¥115.96 Million | ▲ +34.2% |
| 2023 | 0.68x | CN¥163.13 Million | CN¥111.46 Million | ▼ -13.0% |
| 2022 | 0.79x | CN¥94.63 Million | CN¥74.35 Million | ▲ +34.2% |
| 2021 | 0.59x | CN¥163.45 Million | CN¥95.67 Million | ▲ +162.6% |
| 2020 | 0.22x | CN¥114.07 Million | CN¥25.43 Million | — |